BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 3431962)

  • 21. Dietary docosahexaenoic acid has little effect on peroxisomes in healthy mice.
    De Craemer D; Pauwels M; Van den Branden C
    Lipids; 1996 Nov; 31(11):1157-61. PubMed ID: 8934448
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Involvement of carnitine acyltransferases in peroxisomal fatty acid metabolism by the yeast Pichia guilliermondii.
    Pagot Y; Belin JM
    Appl Environ Microbiol; 1996 Oct; 62(10):3864-7. PubMed ID: 8837442
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of the peroxisome proliferator LY171883 on triglyceride accumulation in rats fed a fat-free diet.
    Foxworthy PS; Eacho PI
    Biochem Pharmacol; 1991 Sep; 42(7):1487-91. PubMed ID: 1930273
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lipid accumulation in the livers of chlorpromazine-treated rats does not induce peroxisome proliferation.
    Price SC; Hall DE; Hinton RH
    Toxicol Lett; 1985 Apr; 25(1):11-7. PubMed ID: 2986319
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Peroxisomes in liver, heart, and kidney of mice fed a commercial fish oil preparation: original data and review on peroxisomal changes induced by high-fat diets.
    De Craemer D; Vamecq J; Roels F; Vallée L; Pauwels M; Van den Branden C
    J Lipid Res; 1994 Jul; 35(7):1241-50. PubMed ID: 7964185
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Basic studies on I-123-beta-methyl-p-iodophenylpentadecanoic acid (BMIPP) for myocardial functional diagnosis: effect of beta-oxidation inhibitor].
    Fujibayashi Y; Yonekura Y; Kawai K; Yamamoto K; Tamaki N; Konishi J; Yokoyama A; Torizuka K
    Kaku Igaku; 1988 Oct; 25(10):1131-5. PubMed ID: 3221512
    [No Abstract]   [Full Text] [Related]  

  • 27. Inhibition of carnitine acyltransferase activities by bile acids in rat liver peroxisomes.
    Sekas G; Paul HS
    Biochim Biophys Acta; 1992 Apr; 1125(2):196-202. PubMed ID: 1571363
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term effects of high-fat diets on peroxisomal beta-oxidation in male and female rats.
    Thomassen MS; Norseth J; Christiansen EN
    Lipids; 1985 Oct; 20(10):668-74. PubMed ID: 4058263
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Peroxisomal and mitochondrial proliferation and increased alanine: glyoxylate aminotransferase activity in human liver after chlorpromazine-induced cholestasis.
    Cooper PJ; Danpure CJ; Simpson KJ
    Biochem Soc Trans; 1989 Dec; 17(6):1071-2. PubMed ID: 2628084
    [No Abstract]   [Full Text] [Related]  

  • 30. Peroxisomal beta-oxidation of long fatty acids: effects of high fat diets.
    Osmundsen H
    Ann N Y Acad Sci; 1982; 386():13-29. PubMed ID: 6953843
    [No Abstract]   [Full Text] [Related]  

  • 31. Effects of the acylcarnitine-transferase blocking agent sodium 2[5-(4-chlorophenyl)-pentyl]-oxirane-2-carboxylate (POCA) on metabolism and regional function in the underperfused canine myocardium.
    Seitelberger R; Kraupp O; Winkler M; Brugger G; Raberger G
    J Cardiovasc Pharmacol; 1985; 7(2):273-80. PubMed ID: 2581080
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of inhibition of fatty acid oxidation on neonatal liver carnitine content.
    Frost SC; Wells MA
    Biochem J; 1982 Jun; 204(3):861-3. PubMed ID: 7126171
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chronic inhibition of fatty acid oxidation: new model of diastolic dysfunction.
    Bressler R; Gay R; Copeland JG; Bahl JJ; Bedotto J; Goldman S
    Life Sci; 1989; 44(25):1897-906. PubMed ID: 2661944
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Thioridazine: a selective inhibitor of peroxisomal beta-oxidation in vivo.
    Van den Branden C; Roels F
    FEBS Lett; 1985 Aug; 187(2):331-3. PubMed ID: 4018269
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of dicarboxylic acids on fatty acid-metabolizing enzymes in cultured rat hepatocytes.
    Sato T; Murayama N; Yamazoe Y; Kato R
    Biol Pharm Bull; 1995 Dec; 18(12):1768-9. PubMed ID: 8787804
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hepatic peroxisome (microbody) proliferation in rats fed plasticizers and related compounds.
    Moody DE; Reddy JK
    Toxicol Appl Pharmacol; 1978 Aug; 45(2):497-504. PubMed ID: 705785
    [No Abstract]   [Full Text] [Related]  

  • 37. Hepatic histopathology of a vitamin A overdose in mouse liver.
    Shintaku T; Murata T; Yamaguchi K; Makita T
    J Electron Microsc (Tokyo); 1998; 47(3):263-7. PubMed ID: 9800376
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intraparticulate localization of peroxisomal carnitine acyltransferases in chick embryo liver.
    Ishii S; Ishii H; Watanabe T; Suga T
    Chem Pharm Bull (Tokyo); 1987 Oct; 35(10):4188-93. PubMed ID: 3435942
    [No Abstract]   [Full Text] [Related]  

  • 39. A new experimental model for studies of drug actions on myocardial metabolism. Application to a study of the influence of POCA.
    Bontemps L; Demaison L; Dubois F; Pernin C; Mathieu JP; Vidal M; Comet M; Cuchet P
    Int J Rad Appl Instrum B; 1987; 14(5):459-65. PubMed ID: 3667310
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serial liver-function and blood studies in patients receiving chlorpromazine.
    DEUTSCH L; DICKES R; SCHENKER V
    N Engl J Med; 1957 Jan; 256(1):1-7. PubMed ID: 13388017
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.